Rating History for MapLight Therapeutics (MPLT) by UBS

More Stocks Rated by UBS | Latest Ratings for MPLT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/10/2026 Ashwani Verma Downgrade Neutral
(Buy)		 13.00
(N/A)		 12.17
(13.77)		 13.15% Details